Judit Pich
Clinical trials sponsored by Judit Pich, explained in plain language.
-
Can Immune-Calming cells tame multiple sclerosis?
Disease control OngoingThis Phase 2 trial tests whether infusions of special immune cells (tolerogenic dendritic cells) can reduce brain lesions and relapses in people with relapsing-remitting multiple sclerosis. The 45 participants also take standard MS drugs. The study aims to see if this cell therap…
Phase: PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New HIV remission strategy combines vaccine, antibody, and drug – but trial pulled before start
Disease control TerminatedThis study aimed to see if a personalized RNA vaccine, a powerful antibody (10-1074), and a drug called romidepsin could help people with HIV stop their daily antiretroviral pills while keeping the virus under control. The trial planned to enroll 56 adults with well-controlled HI…
Phase: PHASE1, PHASE2 • Sponsor: Judit Pich • Aim: Disease control
Last updated Jun 26, 2026 15:49 UTC